Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms - Wikidata - awgldk - TriplyDB

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

http://www.wikidata.org/entity/Q35545943

about

Acetaldehyde and parkinsonism: role of CYP450 2E1.The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.Endogenous Isoquinoline Alkaloids Agonists of Acid-Sensing Ion Channel Type 3.

P2860

Q36946015-3E7A5B48-93FD-4F94-93F1-0ECAEBB42D62 Q37583410-550A45F4-3420-4B01-A990-37064FFD4F70 Q41684287-9BC19199-0ADB-4888-9A02-5E32EF72320C

P2860

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

http://www.wikidata.org/entity/Q35545943

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

@ast

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

@en

type

label

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

@ast

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

@en

prefLabel

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

@ast

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

@en

P1433

Q35545943-10B09E7F-F984-4603-A393-DEB41F438692

P1476

Q35545943-09C56D7F-15DB-4CA2-A2DF-95BA5B3BACEA

P2093

Q35545943-0583747A-04D5-4295-AA6B-D08E716764C6

Q35545943-2C55B5D1-ABE5-4993-94DA-E0FE30EB589F

P2860

Q35545943-021D539D-CE14-4572-9ED7-150E231357CB

Q35545943-0F5AD3ED-FB9B-4373-ADC8-9C6C900BE44B

Q35545943-1E15DB7A-7136-4B74-841A-CE240F1115F8

Q35545943-1F9A7D5C-755D-4187-BCEC-C8A240193B1B

Q35545943-2230A1EA-C015-4257-934A-C99C4554D642

Q35545943-253CA9C4-8132-4EF7-99A8-5F0AAE2D1DFE

Q35545943-25717F90-8C73-4A24-A2F7-0823DDDAFA9C

Q35545943-25F9D60A-95A0-4174-8FD0-3BE6DD21A33E

Q35545943-2800572A-E3D2-49E5-82E6-0FB4350BEAC3

Q35545943-30044E8E-0C9F-419E-8BFE-6B36F097EE4F

P304

Q35545943-C2F518D1-1984-4519-AA55-CD00E2CF6FB6

P31

Q35545943-CBB966A0-B23F-4466-9649-A560F2058AB4

P356

Q35545943-25698D03-507F-4FBA-BE10-1B0F337D0D9D

P433

Q35545943-9B3B6DE4-84D4-4123-BF07-A6EC9264419B

P478

Q35545943-D36BCCB8-B65D-4D22-8114-1A58E395EE76

P577

Q35545943-E4D7238B-BE90-4D81-B8BF-9828B77D3BEF

P5875

Q35545943-818D21B0-AB10-43B9-AA4F-9641A9D78736

P698

Q35545943-5B63E72C-3467-4AA9-A83D-7016826EB094

P921

Q35545943-E1C2FAC2-C8BA-4321-A729-A64420E00E75

P932

Q35545943-140AE580-7292-4589-B8C0-5527B131F9E7

P356

EN.2010.19.2.63

P1433

Experimental neurobiology

P1476

Neurotoxic effects of tetrahydroisoquinolines and underlying mechanisms

@en

P2093

Hyun-Jung Kim

http://www.w3.org/2001/XMLSchema#string

Young-Joon Surh

http://www.w3.org/2001/XMLSchema#string

P2860

Nrf2-Keap1 defines a physiologically important stress response mechanism

Partial Purification and Properties of S-Adenosylmethionine: (R), (S)-Norlaudanosoline-6-O-Methyltransferase from Argemone platyceras Cell Cultures

Dopaminergic neurotoxins, 6,7-dihydroxy-1-(3', 4'-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines.

Alcohol induces formation of morphine precursors in the striatum of rats.

Selective dopaminergic neurotoxicity of isoquinoline derivatives related to Parkinson's disease: studies using heterologous expression systems of the dopamine transporter.

Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease.

The oxidant stress hypothesis in Parkinson's disease: evidence supporting it.

Acute exercise and oxidative stress: a 30 year history

Morphine and codeine from mammalian brain.

A review of some aspects of the pharmacology of levodopa.

P304

63-70

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5607/EN.2010.19.2.63

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51823883

http://www.w3.org/2001/XMLSchema#string

P698

22110343

http://www.w3.org/2001/XMLSchema#string

P921

P932

3214777

http://www.w3.org/2001/XMLSchema#string